Consistent with an important role for GCK in beta cell glucose-sensing, humans with GCK-MODY showed greater suppression of C-peptide beginning at low normal blood glucose concentrations (from 3.8 mmolL−1) compared with T2D and healthy controls. The gene discussed is GCK; the disease is type 2 diabetes mellitus.